Gene Therapy Could Be Big Advance Against Hemophilia
THURSDAY, Nov. 18, 2021 (HealthDay News) — Gene therapy shows promise in reducing, and even halting, potentially life-threatening bleeding events in people with hemophilia, researchers report. Hemophilia A is the most common inherited bleeding disorder, affecting one in 5,000 males worldwide. It’s caused by a missing coagulation factor called FVIII.Continue Reading